Oxford vaccine ahead in the race: WHO
Published: 08:34 AM, 27 June 2020
The AstraZeneca vaccine, developed by Oxford University in the United Kingdom, is at the top of the list of possible coronavirus vaccines being tested so far, Chief Scientist of World Health Organization (WHO) said on Friday.
According to a Reuters report, the vaccine, developed by researchers at the British pharmaceutical company AstraZeneca Oxford University, has already begun to be applied to humans on a large and medium scale. They have signed an agreement with a tenth company this week for its production.
Dr. Soumya Swaminathan, Chief Scientist of WHO, said, “Certainly in terms of how advanced they are, the stage at which they are, they are I think probably the leading candidate. So it’s possible they will have results quite early.”
She added that the vaccine, developed by the US Company Moderna, is not far behind than AstraZeneca in terms of development.
Of the more than 200 vaccines made in the world, 15 are undergoing clinical trials.